Larazotide Acetate · Recovery
Larazotide Acetate dosage by bodyweight
Reference dose ranges scaled across bodyweight bands, anchored to the most-cited research dose (500 mcg @ 75 kg). Educational only — never a recommendation.
| Bodyweight band | Reference dose range | At U-100 (1 mg/mL) | Vol. on U-100 (5 mg / 2 mL) | 5× t½ elapsed |
|---|---|---|---|---|
| <60 kg / <132 lb | 312–422 mcg | 0.31–0.42 mL | 13–17 units0.12–0.17 mL | — |
| 60–75 kg / 132–165 lb | 383–518 mcg | 0.38–0.52 mL | 15–21 units0.15–0.21 mL | — |
| 75–90 kg / 165–198 lb | 468–633 mcg | 0.47–0.63 mL | 19–25 units0.19–0.25 mL | — |
| 90–105 kg / 198–231 lb | 553–747 mcg | 0.55–0.75 mL | 22–30 units0.22–0.30 mL | — |
| >105 kg / >231 lb | 638–862 mcg | 0.64–0.86 mL | 26–35 units0.26–0.34 mL | — |
Volume column assumes a standard 5 mg vial reconstituted with 2 mL bacteriostatic water (concentration 2.5 mg/mL); insulin units shown for a U-100 syringe. No published half-life on file for Larazotide Acetate; the elapsed-time column is hidden.
Full profile
Larazotide Acetate guide
Calculator
Reconstitute Larazotide Acetate
Pharmacology
Half-life chart
Larazotide Acetate by goal
Read Larazotide Acetate's profile and dosing through a specific research-goal lens.
⚠
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.